© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Rhythm Pharmaceuticals, Inc. (RYTM) shows an Average True Range (ATR) of 5.24 and an Enterprise Value of 2.33B. Its average trading volume over the past 3 months is 731.72K, indicating liquidity. These fundamental metrics provide insight into RYTM's underlying financial health and market activity.
Rhythm Pharmaceuticals, Inc. (RYTM) technical indicators as of December 23, 2025: the SMA 20 is 4.1%, SMA 50 at 5.84%, and SMA 200 at 35.14%. The RSI 14 value is 58.33, suggesting its current momentum. These technical analysis signals help assess RYTM's price trends and potential future movements.
Rhythm Pharmaceuticals, Inc. (RYTM) stock performance overview as of December 23, 2025: The 52-week high is $122.2 (currently -7.63% below), and the 52-week low is $45.91 (currently 145.9% above). Over the past year, RYTM's performance is 104.31%, compared to the S&P 500's 10.56% change.
According to market data, Rhythm Pharmaceuticals, Inc. (RYTM) stock's recent performance metrics show that over the last month, RYTM is 9.43%, with a Year-to-Date (YTD) performance of 101.64%. Over the past year, the stock has seen a 104.31% change. These figures summarize RYTM's price movements across various periods, reflecting its historical returns.
According to current financial data, RYTM stock's P/E (TTM) ratio is -37.68, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for RYTM, including P/S (43.11), P/B (48.69), and P/FCF (-68.87), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.